Similar articles for PMID: 36564190

Year	Number of Results
2020	10
2021	20
2022	55
2023	4
2024	0

1

Development and Validation of Simple Risk Scores to Predict Hospitalization in Outpatients with COVID-19 Including the Omicron Variant.

Ebell MH, Hamadani R, Kieber-Emmons A. Ebell MH, et al. J Am Board Fam Med. 2022 Dec 23;35(6):1058-1064. doi: 10.3122/jabfm.2022.220056R1. J Am Board Fam Med. 2022. PMID: 36564190 Free article.

2

Development and Validation of Simple Risk Scores to Predict Hospitalization in Outpatients with COVID-19 Including the Omicron Variant.

Ebell MH, Hamadani R, Kieber-Emmons A. Ebell MH, et al. J Am Board Fam Med. 2022 Sep 16:jabfm.2022.AP.220056. doi: 10.3122/jabfm.2022.AP.220056. Online ahead of print. J Am Board Fam Med. 2022. PMID: 36113996

3

External Validation of the COVID-NoLab and COVID-SimpleLab Prognostic Tools.

Ebell MH, Lennon RP, Tarn DM, Barrett B, Krist AH, Dong H, Cai X, Mainous AG 3rd, Zgierska AE, Tuan WJ, Goyal M. Ebell MH, et al. Ann Fam Med. 2022 Nov-Dec;20(6):548-550. doi: 10.1370/afm.2872. Ann Fam Med. 2022. PMID: 36443081 Free PMC article.

4

Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase.

Aggarwal NR, Beaty LE, Bennett TD, Carlson NE, Mayer DA, Molina KC, Peers JL, Russell S, Wynia MK, Ginde AA. Aggarwal NR, et al. Int J Infect Dis. 2023 Mar;128:310-317. doi: 10.1016/j.ijid.2022.10.002. Epub 2022 Oct 10. Int J Infect Dis. 2023. PMID: 36229005 Free PMC article.

5

Development and validation of the OUTCoV score to predict the risk of hospitalisation among patients with SARS-CoV-2 infection in ambulatory settings: a prospective cohort study.

Jacquerioz F, Baggio S, Gayet-Ageron A, Chappuis F, Getaz L, Guessous I, Kaiser L, Vernaz N, Yerly S, Salamun J, Spechbach H. Jacquerioz F, et al. BMJ Open. 2021 Jun 18;11(6):e044242. doi: 10.1136/bmjopen-2020-044242. BMJ Open. 2021. PMID: 34145007 Free PMC article.

6

Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.

Modes ME, Directo MP, Melgar M, Johnson LR, Yang H, Chaudhary P, Bartolini S, Kho N, Noble PW, Isonaka S, Chen P. Modes ME, et al. MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35143466 Free PMC article.

7

Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19.

Jehi L, Ji X, Milinovich A, Erzurum S, Merlino A, Gordon S, Young JB, Kattan MW. Jehi L, et al. PLoS One. 2020 Aug 11;15(8):e0237419. doi: 10.1371/journal.pone.0237419. eCollection 2020. PLoS One. 2020. PMID: 32780765 Free PMC article.

8

Clinical characteristics of the severe acute respiratory syndrome coronavirus 2 omicron variant compared with the delta variant: a retrospective case-control study of 318 outpatients from a single sight institute in Japan.

Suzuki K, Ichikawa T, Suzuki S, Tanino Y, Kakinoki Y. Suzuki K, et al. PeerJ. 2022 Aug 2;10:e13762. doi: 10.7717/peerj.13762. eCollection 2022. PeerJ. 2022. PMID: 35935257 Free PMC article.

9

Admissions to a large tertiary care hospital and Omicron BA.1 and BA.2 SARS-CoV-2 polymerase chain reaction positivity: primary, contributing, or incidental COVID-19.

Voor In 't Holt AF, Haanappel CP, Rahamat-Langendoen J, Molenkamp R, van Nood E, van den Toorn LM, Peeters RP, van Rossum AMC, Severin JA. Voor In 't Holt AF, et al. Int J Infect Dis. 2022 Sep;122:665-668. doi: 10.1016/j.ijid.2022.07.030. Epub 2022 Jul 13. Int J Infect Dis. 2022. PMID: 35842214 Free PMC article.

10

Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.

Haran JP, Pinero JC, Zheng Y, Palma NA, Wingertzahn M. Haran JP, et al. Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0. Trials. 2021. PMID: 33810796 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

84 results

Results by year